HEADER MEMBRANE PROTEIN 12-DEC-19 6TP3 TITLE CRYSTAL STRUCTURE OF THE OREXIN-1 RECEPTOR IN COMPLEX WITH TITLE 2 DARIDOREXANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: OREXIN RECEPTOR TYPE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: OX1R,HYPOCRETIN RECEPTOR TYPE 1; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: DARIDOREXANT BOUND IN THE ORTHOSTERIC SITE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCRTR1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS 7TM, GPCR, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.RAPPAS,A.ALI,K.A.BENNETT,J.D.BROWN,S.J.BUCKNELL,M.CONGREVE, AUTHOR 2 R.M.COOKE,G.CSEKE,C.DE GRAAF,A.S.DORE,J.C.ERREY,A.JAZAYERI, AUTHOR 3 F.H.MARSHALL,J.S.MASON,R.MOULD,J.C.PATEL,B.G.TEHAN,M.WEIR, AUTHOR 4 J.A.CHRISTOPHER REVDAT 6 13-NOV-24 6TP3 1 REMARK REVDAT 5 24-JAN-24 6TP3 1 HETSYN REVDAT 4 29-JUL-20 6TP3 1 COMPND REMARK HETNAM SITE REVDAT 3 11-MAR-20 6TP3 1 JRNL REVDAT 2 29-JAN-20 6TP3 1 JRNL REVDAT 1 01-JAN-20 6TP3 0 JRNL AUTH M.RAPPAS,A.A.E.ALI,K.A.BENNETT,J.D.BROWN,S.J.BUCKNELL, JRNL AUTH 2 M.CONGREVE,R.M.COOKE,G.CSEKE,C.DE GRAAF,A.S.DORE,J.C.ERREY, JRNL AUTH 3 A.JAZAYERI,F.H.MARSHALL,J.S.MASON,R.MOULD,J.C.PATEL, JRNL AUTH 4 B.G.TEHAN,M.WEIR,J.A.CHRISTOPHER JRNL TITL COMPARISON OF OREXIN 1 AND OREXIN 2 LIGAND BINDING MODES JRNL TITL 2 USING X-RAY CRYSTALLOGRAPHY AND COMPUTATIONAL ANALYSIS. JRNL REF J.MED.CHEM. V. 63 1528 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 31860301 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01787 REMARK 2 REMARK 2 RESOLUTION. 3.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 58.6 REMARK 3 NUMBER OF REFLECTIONS : 13842 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 700 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.04 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.32 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 7.25 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2149 REMARK 3 BIN FREE R VALUE : 0.2547 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 28 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4982 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 417 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 121.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.63550 REMARK 3 B22 (A**2) : 2.21300 REMARK 3 B33 (A**2) : 1.42250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.05500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.440 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.498 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.891 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5594 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7630 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1936 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 833 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5594 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 731 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6524 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|33 - 377} REMARK 3 ORIGIN FOR THE GROUP (A): -24.0054 24.9609 -25.1908 REMARK 3 T TENSOR REMARK 3 T11: -0.0464 T22: -0.2733 REMARK 3 T33: -0.2933 T12: 0.1317 REMARK 3 T13: 0.0608 T23: 0.0833 REMARK 3 L TENSOR REMARK 3 L11: 2.6402 L22: 5.7085 REMARK 3 L33: 3.1093 L12: -0.6422 REMARK 3 L13: 0.0452 L23: 1.3706 REMARK 3 S TENSOR REMARK 3 S11: 0.1115 S12: -0.6704 S13: 0.1417 REMARK 3 S21: -0.6704 S22: -0.0072 S23: -0.2533 REMARK 3 S31: 0.1417 S32: -0.2533 S33: -0.1044 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|27 - 378} REMARK 3 ORIGIN FOR THE GROUP (A): -15.7496 47.5332 -1.0274 REMARK 3 T TENSOR REMARK 3 T11: -0.3186 T22: -0.2655 REMARK 3 T33: 0.0533 T12: 0.1245 REMARK 3 T13: -0.0429 T23: 0.1034 REMARK 3 L TENSOR REMARK 3 L11: 1.3064 L22: 4.7838 REMARK 3 L33: 3.5861 L12: 0.0151 REMARK 3 L13: -0.4614 L23: 2.1341 REMARK 3 S TENSOR REMARK 3 S11: 0.1241 S12: 0.3058 S13: -0.3281 REMARK 3 S21: 0.3058 S22: 0.1043 S23: 0.4013 REMARK 3 S31: -0.3281 S32: 0.4013 S33: -0.2284 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6TP3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1292105824. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.0-6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96858 REMARK 200 MONOCHROMATOR : SI (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13842 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.040 REMARK 200 RESOLUTION RANGE LOW (A) : 25.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 58.6 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 7.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6TO7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRISODIUM CITRATE 50MM SODIUM REMARK 280 CHLORIDE 50MM LITHIUM SULPHATE 15-34% PEG400, PH 4.8, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 73.21150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 25 REMARK 465 ALA A 26 REMARK 465 SER A 27 REMARK 465 GLU A 28 REMARK 465 ASP A 29 REMARK 465 GLU A 30 REMARK 465 PHE A 31 REMARK 465 SER A 251A REMARK 465 ALA A 251B REMARK 465 LEU A 251C REMARK 465 VAL A 251D REMARK 465 ARG A 251E REMARK 465 ASN A 251F REMARK 465 TRP A 251G REMARK 465 LYS A 251H REMARK 465 ARG A 251I REMARK 465 PRO A 251J REMARK 465 SER A 251K REMARK 465 ASP A 251L REMARK 465 GLN A 251M REMARK 465 LEU A 251N REMARK 465 GLY A 251O REMARK 465 ASP A 251P REMARK 465 LEU A 251Q REMARK 465 GLU A 251R REMARK 465 GLN A 251S REMARK 465 GLY A 251T REMARK 465 LEU A 251U REMARK 465 GLY A 252A REMARK 465 GLU A 252B REMARK 465 PRO A 252C REMARK 465 GLN A 252D REMARK 465 PRO A 252E REMARK 465 ARG A 252F REMARK 465 ALA A 252G REMARK 465 ARG A 252H REMARK 465 ALA A 252I REMARK 465 PHE A 252J REMARK 465 LEU A 252K REMARK 465 PRO A 378 REMARK 465 GLY A 379 REMARK 465 LEU A 380 REMARK 465 ALA A 381 REMARK 465 ALA A 382 REMARK 465 ALA A 383 REMARK 465 HIS A 384 REMARK 465 HIS A 385 REMARK 465 HIS A 386 REMARK 465 HIS A 387 REMARK 465 HIS A 388 REMARK 465 HIS A 389 REMARK 465 HIS A 390 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 ALA B 25 REMARK 465 ALA B 26 REMARK 465 VAL B 188 REMARK 465 LEU B 189 REMARK 465 PRO B 190 REMARK 465 GLU B 191 REMARK 465 LEU B 192 REMARK 465 ALA B 193 REMARK 465 ALA B 194 REMARK 465 ARG B 195 REMARK 465 THR B 196 REMARK 465 ARG B 197 REMARK 465 ALA B 198 REMARK 465 GLY B 244 REMARK 465 ARG B 245 REMARK 465 SER B 251A REMARK 465 ALA B 251B REMARK 465 LEU B 251C REMARK 465 VAL B 251D REMARK 465 ARG B 251E REMARK 465 ASN B 251F REMARK 465 TRP B 251G REMARK 465 LYS B 251H REMARK 465 ARG B 251I REMARK 465 PRO B 251J REMARK 465 SER B 251K REMARK 465 ASP B 251L REMARK 465 GLN B 251M REMARK 465 LEU B 251N REMARK 465 GLY B 251O REMARK 465 ASP B 251P REMARK 465 LEU B 251Q REMARK 465 GLU B 251R REMARK 465 GLN B 251S REMARK 465 GLY B 251T REMARK 465 LEU B 251U REMARK 465 GLY B 252A REMARK 465 GLU B 252B REMARK 465 PRO B 252C REMARK 465 GLN B 252D REMARK 465 PRO B 252E REMARK 465 ARG B 252F REMARK 465 ALA B 252G REMARK 465 ARG B 252H REMARK 465 ALA B 252I REMARK 465 PHE B 252J REMARK 465 LEU B 252K REMARK 465 GLY B 379 REMARK 465 LEU B 380 REMARK 465 ALA B 381 REMARK 465 ALA B 382 REMARK 465 ALA B 383 REMARK 465 HIS B 384 REMARK 465 HIS B 385 REMARK 465 HIS B 386 REMARK 465 HIS B 387 REMARK 465 HIS B 388 REMARK 465 HIS B 389 REMARK 465 HIS B 390 REMARK 465 HIS B 391 REMARK 465 HIS B 392 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 43 O ASP A 107 2.16 REMARK 500 OH TYR B 224 O ALA B 308 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CE1 TYR A 41 CD2 LEU B 40 2445 1.22 REMARK 500 CD1 TYR A 41 CD2 LEU B 40 2445 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 42 C - N - CD ANGL. DEV. = -18.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 41 -75.31 -77.35 REMARK 500 TYR A 224 -65.73 -138.78 REMARK 500 TYR B 39 -65.39 -139.63 REMARK 500 LEU B 152 31.43 -99.70 REMARK 500 ILE B 247 49.55 -157.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 SOG A 408 REMARK 610 SOG B 406 REMARK 610 SOG B 407 REMARK 610 SOG B 408 REMARK 610 SOG B 409 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6TOT RELATED DB: PDB REMARK 900 RELATED ID: 6TOS RELATED DB: PDB REMARK 900 RELATED ID: 6TOD RELATED DB: PDB REMARK 900 RELATED ID: 6TO7 RELATED DB: PDB DBREF 6TP3 A 28 380 UNP O43613 OX1R_HUMAN 28 380 DBREF 6TP3 B 28 380 UNP O43613 OX1R_HUMAN 28 380 SEQADV 6TP3 ALA A 25 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA A 26 UNP O43613 EXPRESSION TAG SEQADV 6TP3 SER A 27 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA A 46 UNP O43613 GLU 46 ENGINEERED MUTATION SEQADV 6TP3 LEU A 85 UNP O43613 ILE 85 ENGINEERED MUTATION SEQADV 6TP3 ALA A 95 UNP O43613 VAL 95 ENGINEERED MUTATION SEQADV 6TP3 LEU A 162 UNP O43613 ARG 162 ENGINEERED MUTATION SEQADV 6TP3 ALA A 194 UNP O43613 ASN 194 ENGINEERED MUTATION SEQADV 6TP3 ALA A 198 UNP O43613 LEU 198 ENGINEERED MUTATION SEQADV 6TP3 ALA A 211 UNP O43613 TYR 211 ENGINEERED MUTATION SEQADV 6TP3 VAL A 304 UNP O43613 LEU 304 ENGINEERED MUTATION SEQADV 6TP3 ALA A 339 UNP O43613 CYS 339 ENGINEERED MUTATION SEQADV 6TP3 TRP A 375 UNP O43613 CYS 375 ENGINEERED MUTATION SEQADV 6TP3 TRP A 376 UNP O43613 CYS 376 ENGINEERED MUTATION SEQADV 6TP3 ALA A 381 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA A 382 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA A 383 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 384 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 385 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 386 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 387 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 388 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 389 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 390 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 391 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS A 392 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA B 25 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA B 26 UNP O43613 EXPRESSION TAG SEQADV 6TP3 SER B 27 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA B 46 UNP O43613 GLU 46 ENGINEERED MUTATION SEQADV 6TP3 LEU B 85 UNP O43613 ILE 85 ENGINEERED MUTATION SEQADV 6TP3 ALA B 95 UNP O43613 VAL 95 ENGINEERED MUTATION SEQADV 6TP3 LEU B 162 UNP O43613 ARG 162 ENGINEERED MUTATION SEQADV 6TP3 ALA B 194 UNP O43613 ASN 194 ENGINEERED MUTATION SEQADV 6TP3 ALA B 198 UNP O43613 LEU 198 ENGINEERED MUTATION SEQADV 6TP3 ALA B 211 UNP O43613 TYR 211 ENGINEERED MUTATION SEQADV 6TP3 VAL B 304 UNP O43613 LEU 304 ENGINEERED MUTATION SEQADV 6TP3 ALA B 339 UNP O43613 CYS 339 ENGINEERED MUTATION SEQADV 6TP3 TRP B 375 UNP O43613 CYS 375 ENGINEERED MUTATION SEQADV 6TP3 TRP B 376 UNP O43613 CYS 376 ENGINEERED MUTATION SEQADV 6TP3 ALA B 381 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA B 382 UNP O43613 EXPRESSION TAG SEQADV 6TP3 ALA B 383 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 384 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 385 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 386 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 387 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 388 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 389 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 390 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 391 UNP O43613 EXPRESSION TAG SEQADV 6TP3 HIS B 392 UNP O43613 EXPRESSION TAG SEQRES 1 A 368 ALA ALA SER GLU ASP GLU PHE LEU ARG TYR LEU TRP ARG SEQRES 2 A 368 ASP TYR LEU TYR PRO LYS GLN TYR ALA TRP VAL LEU ILE SEQRES 3 A 368 ALA ALA TYR VAL ALA VAL PHE VAL VAL ALA LEU VAL GLY SEQRES 4 A 368 ASN THR LEU VAL CYS LEU ALA VAL TRP ARG ASN HIS HIS SEQRES 5 A 368 MET ARG THR VAL THR ASN TYR PHE LEU VAL ASN LEU SER SEQRES 6 A 368 LEU ALA ASP VAL LEU ALA THR ALA ILE CYS LEU PRO ALA SEQRES 7 A 368 SER LEU LEU VAL ASP ILE THR GLU SER TRP LEU PHE GLY SEQRES 8 A 368 HIS ALA LEU CYS LYS VAL ILE PRO TYR LEU GLN ALA VAL SEQRES 9 A 368 SER VAL SER VAL ALA VAL LEU THR LEU SER PHE ILE ALA SEQRES 10 A 368 LEU ASP ARG TRP TYR ALA ILE CYS HIS PRO LEU LEU PHE SEQRES 11 A 368 LYS SER THR ALA ARG ARG ALA LEU GLY SER ILE LEU GLY SEQRES 12 A 368 ILE TRP ALA VAL SER LEU ALA ILE MET VAL PRO GLN ALA SEQRES 13 A 368 ALA VAL MET GLU CYS SER SER VAL LEU PRO GLU LEU ALA SEQRES 14 A 368 ALA ARG THR ARG ALA PHE SER VAL CYS ASP GLU ARG TRP SEQRES 15 A 368 ALA ASP ASP LEU ALA PRO LYS ILE TYR HIS SER CYS PHE SEQRES 16 A 368 PHE ILE VAL THR TYR LEU ALA PRO LEU GLY LEU MET ALA SEQRES 17 A 368 MET ALA TYR PHE GLN ILE PHE ARG LYS LEU TRP GLY ARG SEQRES 18 A 368 GLN ILE PRO GLY THR THR SER ALA LEU VAL ARG ASN TRP SEQRES 19 A 368 LYS ARG PRO SER ASP GLN LEU GLY ASP LEU GLU GLN GLY SEQRES 20 A 368 LEU SER GLY GLU PRO GLN PRO ARG ALA ARG ALA PHE LEU SEQRES 21 A 368 ALA GLU VAL LYS GLN MET ARG ALA ARG ARG LYS THR ALA SEQRES 22 A 368 LYS MET LEU MET VAL VAL VAL LEU VAL PHE ALA LEU CYS SEQRES 23 A 368 TYR LEU PRO ILE SER VAL LEU ASN VAL LEU LYS ARG VAL SEQRES 24 A 368 PHE GLY MET PHE ARG GLN ALA SER ASP ARG GLU ALA VAL SEQRES 25 A 368 TYR ALA ALA PHE THR PHE SER HIS TRP LEU VAL TYR ALA SEQRES 26 A 368 ASN SER ALA ALA ASN PRO ILE ILE TYR ASN PHE LEU SER SEQRES 27 A 368 GLY LYS PHE ARG GLU GLN PHE LYS ALA ALA PHE SER TRP SEQRES 28 A 368 TRP LEU PRO GLY LEU ALA ALA ALA HIS HIS HIS HIS HIS SEQRES 29 A 368 HIS HIS HIS HIS SEQRES 1 B 368 ALA ALA SER GLU ASP GLU PHE LEU ARG TYR LEU TRP ARG SEQRES 2 B 368 ASP TYR LEU TYR PRO LYS GLN TYR ALA TRP VAL LEU ILE SEQRES 3 B 368 ALA ALA TYR VAL ALA VAL PHE VAL VAL ALA LEU VAL GLY SEQRES 4 B 368 ASN THR LEU VAL CYS LEU ALA VAL TRP ARG ASN HIS HIS SEQRES 5 B 368 MET ARG THR VAL THR ASN TYR PHE LEU VAL ASN LEU SER SEQRES 6 B 368 LEU ALA ASP VAL LEU ALA THR ALA ILE CYS LEU PRO ALA SEQRES 7 B 368 SER LEU LEU VAL ASP ILE THR GLU SER TRP LEU PHE GLY SEQRES 8 B 368 HIS ALA LEU CYS LYS VAL ILE PRO TYR LEU GLN ALA VAL SEQRES 9 B 368 SER VAL SER VAL ALA VAL LEU THR LEU SER PHE ILE ALA SEQRES 10 B 368 LEU ASP ARG TRP TYR ALA ILE CYS HIS PRO LEU LEU PHE SEQRES 11 B 368 LYS SER THR ALA ARG ARG ALA LEU GLY SER ILE LEU GLY SEQRES 12 B 368 ILE TRP ALA VAL SER LEU ALA ILE MET VAL PRO GLN ALA SEQRES 13 B 368 ALA VAL MET GLU CYS SER SER VAL LEU PRO GLU LEU ALA SEQRES 14 B 368 ALA ARG THR ARG ALA PHE SER VAL CYS ASP GLU ARG TRP SEQRES 15 B 368 ALA ASP ASP LEU ALA PRO LYS ILE TYR HIS SER CYS PHE SEQRES 16 B 368 PHE ILE VAL THR TYR LEU ALA PRO LEU GLY LEU MET ALA SEQRES 17 B 368 MET ALA TYR PHE GLN ILE PHE ARG LYS LEU TRP GLY ARG SEQRES 18 B 368 GLN ILE PRO GLY THR THR SER ALA LEU VAL ARG ASN TRP SEQRES 19 B 368 LYS ARG PRO SER ASP GLN LEU GLY ASP LEU GLU GLN GLY SEQRES 20 B 368 LEU SER GLY GLU PRO GLN PRO ARG ALA ARG ALA PHE LEU SEQRES 21 B 368 ALA GLU VAL LYS GLN MET ARG ALA ARG ARG LYS THR ALA SEQRES 22 B 368 LYS MET LEU MET VAL VAL VAL LEU VAL PHE ALA LEU CYS SEQRES 23 B 368 TYR LEU PRO ILE SER VAL LEU ASN VAL LEU LYS ARG VAL SEQRES 24 B 368 PHE GLY MET PHE ARG GLN ALA SER ASP ARG GLU ALA VAL SEQRES 25 B 368 TYR ALA ALA PHE THR PHE SER HIS TRP LEU VAL TYR ALA SEQRES 26 B 368 ASN SER ALA ALA ASN PRO ILE ILE TYR ASN PHE LEU SER SEQRES 27 B 368 GLY LYS PHE ARG GLU GLN PHE LYS ALA ALA PHE SER TRP SEQRES 28 B 368 TRP LEU PRO GLY LEU ALA ALA ALA HIS HIS HIS HIS HIS SEQRES 29 B 368 HIS HIS HIS HIS HET NS2 A 401 55 HET SO4 A 402 5 HET SO4 A 403 5 HET PGW A 404 51 HET SOG A 405 20 HET SOG A 406 20 HET SOG A 407 20 HET SOG A 408 14 HET SOG A 409 20 HET SOG A 410 20 HET SOG A 411 20 HET NS2 B 401 55 HET SO4 B 402 5 HET PGW B 403 51 HET SOG B 404 20 HET SOG B 405 20 HET SOG B 406 13 HET SOG B 407 5 HET SOG B 408 12 HET SOG B 409 12 HET SOG B 410 20 HETNAM NS2 [(2~{S})-2-(6-CHLORANYL-7-METHYL-1~{H}-BENZIMIDAZOL-2- HETNAM 2 NS2 YL)-2-METHYL-PYRROLIDIN-1-YL]-[5-METHOXY-2-(1,2,3- HETNAM 3 NS2 TRIAZOL-2-YL)PHENYL]METHANONE HETNAM SO4 SULFATE ION HETNAM PGW (1R)-2-{[(S)-{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY) HETNAM 2 PGW PHOSPHORYL]OXY}-1-[(HEXADECANOYLOXY)METHYL]ETHYL (9Z)- HETNAM 3 PGW OCTADEC-9-ENOATE HETNAM SOG OCTYL 1-THIO-BETA-D-GLUCOPYRANOSIDE HETSYN PGW 1-PALMITOYL-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-(1- HETSYN 2 PGW GLYCEROL)]; PHOSPHATIDYLGLYCEROL HETSYN SOG 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5- HETSYN 2 SOG TRIOL; 1-S-OCTYL-BETA-D-THIOGLUCOSIDE; OCTYL 1-THIO- HETSYN 3 SOG BETA-D-GLUCOSIDE; OCTYL 1-THIO-D-GLUCOSIDE; OCTYL 1- HETSYN 4 SOG THIO-GLUCOSIDE FORMUL 3 NS2 2(C23 H23 CL N6 O2) FORMUL 4 SO4 3(O4 S 2-) FORMUL 6 PGW 2(C40 H77 O10 P) FORMUL 7 SOG 14(C14 H28 O5 S) HELIX 1 AA1 TYR A 45 ASN A 74 1 30 HELIX 2 AA2 HIS A 75 ARG A 78 5 4 HELIX 3 AA3 THR A 79 ILE A 98 1 20 HELIX 4 AA4 ILE A 98 GLU A 110 1 13 HELIX 5 AA5 PHE A 114 CYS A 149 1 36 HELIX 6 AA6 THR A 157 MET A 176 1 20 HELIX 7 AA7 MET A 176 VAL A 182 1 7 HELIX 8 AA8 LEU A 189 ARG A 195 5 7 HELIX 9 AA9 ASP A 209 TYR A 224 1 16 HELIX 10 AB1 TYR A 224 TRP A 243 1 20 HELIX 11 AB2 THR A 251 VAL A 323 1 41 HELIX 12 AB3 ASP A 332 SER A 362 1 31 HELIX 13 AB4 SER A 362 LEU A 377 1 16 HELIX 14 AB5 GLU B 28 TYR B 39 1 12 HELIX 15 AB6 TYR B 39 ASN B 74 1 36 HELIX 16 AB7 HIS B 75 ARG B 78 5 4 HELIX 17 AB8 THR B 79 ILE B 98 1 20 HELIX 18 AB9 ILE B 98 GLU B 110 1 13 HELIX 19 AC1 PHE B 114 CYS B 149 1 36 HELIX 20 AC2 THR B 157 MET B 176 1 20 HELIX 21 AC3 MET B 176 VAL B 182 1 7 HELIX 22 AC4 ASP B 209 TYR B 224 1 16 HELIX 23 AC5 TYR B 224 TRP B 243 1 20 HELIX 24 AC6 ALA B 253 VAL B 323 1 39 HELIX 25 AC7 ASP B 332 SER B 362 1 31 HELIX 26 AC8 SER B 362 TRP B 376 1 15 SHEET 1 AA1 2 MET A 183 SER A 187 0 SHEET 2 AA1 2 SER A 200 GLU A 204 -1 O ASP A 203 N GLU A 184 SHEET 1 AA2 2 MET B 183 SER B 186 0 SHEET 2 AA2 2 VAL B 201 GLU B 204 -1 O ASP B 203 N GLU B 184 SSBOND 1 CYS A 119 CYS A 202 1555 1555 2.06 SSBOND 2 CYS B 119 CYS B 202 1555 1555 2.04 CRYST1 61.223 146.423 73.600 90.00 109.55 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016334 0.000000 0.005800 0.00000 SCALE2 0.000000 0.006830 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014418 0.00000